IVV vs BBC

AIVV

BBBC

Measures won4–2IVV wins · of 6 · 5Y

$10,000 · 5Y$17,177IVV · SPY $17,118

Lowest cost0.03%IVV · $3 on $10k

Most income1.52%BBC · $152 on $10k

Smallest drop−8.9%SPY · worst fall in 1Y

Held in common0.0%IVV and BBC

IVV

BBC

iShares Core S&P 500 ETF · $850BVirtus Biotech Clinical Trials ETF · $34M

+21.8%3 years · per year$18,084 · $24,485+34.8%

+11.4%5 years · per year$17,177 · $9,995−0.0%

0.03%Expense ratio$3 · $65 on $10k · lower wins0.65%

1.14%12-mo yield$114 · $152 on $10k1.52%

−8.9%Worst dropSmaller wins−30.2%

13.6%VolatilityLower wins38.6%

4–2IVV wins

$10,000 · 5 yearsAll three, one scale

Shared top holdingsIVV · BBC

They share no top holdings, or holdings aren’t on file […]

Held in common0.0%

End-of-day Nov 6, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

All Three

5Y3 funds

#
1	AIVV	iShares Core S&P 500 ETFRead Desk	0.03%	1.14%	+0.3%	+8.7%	+9.8%	+21.8%	+11.4%	−8.9%	$850.0B
2	SPY	State Street SPDR S&P 500 ETFRead Desk	0.09%	1.03%	+0.3%	+8.7%	+9.7%	+21.7%	+11.3%	−8.9%	$818.5B
3	BBBC	Virtus Biotech Clinical Trials ETFRead Desk	0.65%	1.52%	+5.6%	+11.6%	+46.1%	+34.8%	0.0%	−30.2%	$34M

End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

All Three

5Y3 funds

#
1	AIVV	iShares Core S&P 500 ETFRead Desk	0.03%	1.14%	+0.3%	+8.7%	+9.8%	+21.8%	+11.4%	−8.9%	$850.0B
2	SPY	State Street SPDR S&P 500 ETFRead Desk	0.09%	1.03%	+0.3%	+8.7%	+9.7%	+21.7%	+11.3%	−8.9%	$818.5B
3	BBBC	Virtus Biotech Clinical Trials ETFRead Desk	0.65%	1.52%	+5.6%	+11.6%	+46.1%	+34.8%	0.0%	−30.2%	$34M

End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

IVV vs BBC

IVV

iShares Core S&P 500

$17,177

BBC

Virtus Biotech Clinical Trials

$9,995

MeasureIVVBBC

Fee0.03%0.65%

Cost on $10k a year$3$65

Yield1.14%1.52%

5 years, per year+11.4%−0.0%

3 years, per year+21.8%+34.8%

Worst drop · 1Y−8.9%−30.2%

Volatility · 1Y13.6%38.6%

4–2measures won
IVV first

0.0%

holdings shared

Nov 6, 2026 · $10,000 five years ago, dividends reinvested

SPYM vs SPY

YTD

SPDRSPYM

+8.8%

SPYSPDR

+8.7%

+8.8%Year to date+8.7%

1.1%Yield1.0%

$182BAssets$819B

2–0SPYM wins

End-of-day Nov 6, 2026

VOO vs IVV

YTD

VanguardVOO

+8.7%

IVViShares

+8.7%

+8.7%Year to date+8.7%

1.1%Yield1.1%

$1.00TAssets$850B

0–0level

End-of-day Nov 6, 2026

SCHD vs VIG

YTD

SchwabSCHD

+31.4%

VIGVanguard

+12.1%

+31.4%Year to date+12.1%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 6, 2026

Overlap: IVV, BBC, SPY

Today

99.9%most shared, IVV and SPY

IVVBBCSPY

IVV—0.0%99.9%

BBC0.0%—0.0%

SPY99.9%0.0%—

End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus

Income After Fees on $10,000

$111most kept, IVV

IVV$114 − $3 = $111

SPY$103 − $9 = $94

BBC$152 − $65 = $87

KeptFee

End-of-day Nov 6, 2026 · yield in dollars minus the fee